Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment

Scandinavian Journal of Immunology

Volumn 49, Issue 5, 1999, Pages 539-547

  Ullum, H ^a   Katzenstein, T ^a   Aladdin, H ^a   Nielsen, C ^b   Sondergaard S R ^a   Gerstoft, J ^a   Skinhoj P ^a   Pedersen, B K ^a  

^a Rigshospitalet   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 2; LAMIVUDINE; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; PROTEINASE INHIBITOR; RITONAVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FOLLOW UP; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADULT; AGED; ANTI-HIV AGENTS; ANTIGENS, CD; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RITONAVIR; VIRAL LOAD;

EID: 0032976857     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00532.x     Document Type: Article

References (31)

1. Fauci AS. Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS). Clin Res 1984;32:491-9.
2. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Sci 1996;272:1167-70.
3. Katzenstein T, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73.
4. Hofmann B, Lindhardt BO, Gerstoft J et al. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J Clin Res Ed 1987;295:293-6.
5. Roos MT, Miedema F, de Meinesz AP et al. Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression. Clin Exp Immunol 1996;105:409-15.
6. Borthwick NJ, Bofill M, Gombert WM et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS 1994;8:431-41.
7. + lymphocytes in late stages of HIV infection is related to disease progression: evidence from a cohort of 347 HIV-infected individuals. AIDS 1997;11:1479-85.
8. Ullum H, Gøtzsche PC, Victor J, Dickmeiss E, Skinhøj P, Pedersen BK. Defective natural immunity - an early manifestation of human immunodeficiency virus infection. J Exp Med 1995;182:789-800.
9. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-10.
10. Koup RA, Safrit JT, Cao Y et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-5.
11. Goulder PJ, Phillips RE, Colbert RA et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-7.
12. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
13. Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
14. Mouton Y, Cartier F, Dellamonica P et al. Dramatic cut in AIDS defining events and hospitalization for patients under protease inhibitors and tritherapies in 9 AIDS Reference Centers (Abstract). 4th Conference on Retroviruses and Opportunistic Infections 1997.
15. Jacobson MA, Zegans M, Pavan P et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.
16. Rinaldo C, Huang XL, Piazza P et al. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J Infect Dis 1991;164:638-45.
17. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996;173:321-9.
18. Pakker NG, Notermans MD, Miedema F et al. Immunological reconstitution after triple combination therapy in HIV-1 infection (Abstract). International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication 1997.
19. Hofmann B, Jakobsen KD, Ødum N et al. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. J Immunol 1989;142:1874-80.
20. Welsh RM. Regulation of virus infections by natural killer cells. Ann Rev Nat Immun Cell Growth Regul 1986;5:169-99.
21. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
22. Tvede N, Pedersen BK, Hansen FR et al. Effect of physical exercise on blood mononuclear cell subpopulations and in vitro proliferative responses. Scand J Immunol 1989;29:383-9.
23. Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988;336:484-7.
24. Nielsen C, Nielsen CM, Petersen JL et al. Isolation of HIV from cultures of purified CD4+ lymphocytes. J Virol Meth 1991;35: 15-25.
25. Nielsen C, Pedersen C, Lundgren JD, Gerstoft J. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 1993;7:1035-40.
26. Connors M, Kovacs JA, Krevat S et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Medicine 1997;3:533-40.
27. Ceuppens JL, Meurs L, Baroja ML, van Wauwe JP. Effect of T3 modulation on pokeweed mitogen-induced T cell activation: evidence for an alternative pathway of T cell activation. J Immunol 1986;136:3346-50.
28. Autran B, Carcelain G, Li TS et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Sci 1997;277:112-6.
29. Kost R, Markowitz M, Hurley A et al. Partial immunological recovery after 13 months of potent antiretroviral therapy (Abstract). International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, 1997:80-1.
30. McChesney M, Tanneau F, Regnault A et al. Detection of primary cytotoxic T lympocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur J Immunol 1990;20:215-20.
31. Riviere Y, Tanneau Salvadori F, Regnault A et al. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol 1989;63: 2270-7.